Cargando…

337 Targeting metabolic and epigenetic programs to re-sensitize glioblastoma to chemotherapy

OBJECTIVES/GOALS: Treatment options for glioblastoma (GBM) are limited. Prognosis remains dismal, with an 18 month on average survival rate following diagnosis due to treatment resistance and disease recurrence. The goal of this project is to investigate hallmarks of cancer progression that contribu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rowland, Emma, Walter, Thomas, Suter, Robert, Jermakowicz, Anna, Riggins, Rebecca, Ayad, Nagi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129721/
http://dx.doi.org/10.1017/cts.2023.382

Ejemplares similares